The global smart pills market is estimated to grow at a CAGR of 11.4% during the forecast period. The increasing geriatric population coupled with the growing prevalence of lifestyle-related disorders such as obesity, gastric ulcers, and gastroesophageal reflux disease (GERD) are some of the factors augmenting the global smart pills market. Further, the rise in chronic disorders such as cancer, diabetes, and others are also driving the market growth. Patients with certain lifestyle disorders are preferring minimally invasive procedures which are offering a significant opportunity for the growth of smart pills. Further, the increasing investments in R&D for the development of the smart pill will further drive the market growth.
Market Segmentation
The global smart pills market has been analyzed on the basis of application, disease indication, target area, end user, and region. Based on application, the market is segmented into capsule endoscopy, patient monitoring, and drug delivery. The capsule endoscopy segment is gaining significant traction in the market. Based on disease indication, the market is segmented into esophageal diseases, colon diseases, digestive tract disease, small bowel tumors, and others. Among these, esophageal diseases segment is projected to contribute significantly to the market.
Based on target area, the market is further segmented into large intestine, small intestine, stomach, and esophagus. Among these, stomach segment is projected to exhibit considerable growth rate during the forecast period. Further, on the basis of end-user, the market is segmented into hospitals, diagnostics center, academic & research institutes, and others. Hospital segment is projected to hold a prominent share in the market. Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is estimated to exhibit a remarkable growth during the forecast period.
Market Structure and Competition Landscape
The global smart pills market is characterized by the presence of significant number of players. Some of the prominent players operating in the market include Otsuka Holding Co., Ltd., CapsoVision, Inc., GE Healthcare (General Electric Company), Boston Scientific Corporation, Medtronic PLC, RF Co. Ltd., Jinshan Science & Technology (Group) Co., Ltd., Veloce Corporation, and others. To maintain their market position, these industry players focus on various growth strategies such as partnerships, mergers and acquisitions, and product portfolio expansion. Some of the key developments in the smart pills market include:
• In January 2021, etectRx Inc. and Pear Therapeutics Inc. entered into a partnership agreement for the development of two CNS product candidates integrating adherence sensors and PDTs (Prescription Digital Therapeutics). This is the first partnership of its kind to investigate the use of digital pill solutions with PDTs.
• In September 2020, CapsoVision announced that the US Food and Drug Administration (FDA) would allow at-home administration of the CapsoCam Plus small bowel capsule endoscope during the COVID-19 pandemic for patients deemed eligible for at-home administration.
Global Smart Pills Market Analysis and Forecast 2019-2028
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Per Capita Income in Key Countries
6.1.3. Healthcare Spending Per Capita in Key Countries
6.1.4. Consumer Spending on Smart Pills by Region
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players' expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1. Raw Material Suppliers
6.3.1.1. Pharmaceutical Raw Material Suppliers
6.3.1.2. Edible Electronic Components Suppliers
6.3.2. Smart Pills Manufacturers
6.3.3. Key End Users
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter's Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Smart Pills Market: Key Investment Analysis
9.1. By Electronics Companies
9.2. By Sensors and Components Providers
9.3. Technological Assessment
9.4. By Application
9.5. By Region
9.6. M&A Activities
Robust assessment of major investments made by various industry players in the areas ranging from the application, technology, etc.
10. Global Smart Pills Market: Patent Analysis
10.1. By Key Industry Players
10.2. By Application
10.3. By Region
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. Asia Pacific
10.3.6. Middle East & Africa
11. Global Smart Pills Market: Clinical Trials Analysis
11.1. Phase 1 Clinical Trials
11.2. Phase 2 Clinical Trials
11.3. Phase 3 Clinical Trials
11.4. Monitoring Post-FDA Approval
12. Global Smart Pills Market: Pipeline Analysis
12.1. By Key Industry Players
12.2. By Application
12.3. By Region
12.3.1. North America
12.3.2. Latin America
12.3.3. Western Europe
12.3.4. Eastern Europe
12.3.5. Asia Pacific
12.3.6. Middle East & Africa
13. Regional Penetration of Smart Pills
13.1. North America
13.2. Latin America
13.3. Western Europe
13.4. Eastern Europe
13.5. Asia Pacific
13.6. Middle East & Africa
14. Pricing Analysis
14.1. By Application
14.2. By End User
14.3. By Region
14.3.1. North America
14.3.2. Western Europe
14.3.3. Eastern Europe
14.3.4. Asia Pacific
14.3.5. Latin America
14.3.6. Middle East & Africa
15. Parent Market Overview
15.1. Global Pharmaceutical Market by Value (US$ Million) and Volume (Million Tons)
15.2. Global Electronic Devices Market by Value (US$ Million) and Volume (Million Units)
16. Segmental Analysis
16.1. Global Smart Pills Market by Application
16.1.1. Segment Overview
16.1.1.1. Capsule Endoscopy
16.1.1.2. Patient Monitoring
16.1.1.3. Drug Delivery
16.2. Global Smart Pills Market by Disease Indication
16.2.1. Segment Overview
16.2.1.1. Esophageal Diseases
16.2.1.2. Colon Diseases
16.2.1.3. Digestive Tract Disease
16.2.1.4. Small Bowel Tumors
16.2.1.5. Others (Chrons's Disease, Celiac Disease, Inherited Polyposis Syndrome)
16.3. Global Smart Pills Market by Target Area
16.3.1. Segment Overview
16.3.1.1. Large Intestine
16.3.1.2. Small Intestine
16.3.1.3. Stomach
16.3.1.4. Esophagus
16.3.1.5. Others (Chrons's Disease, Celiac Disease, Inherited Polyposis Syndrome)
16.4. Global Smart Pills Market by End User
16.4.1. Segment Overview
16.4.1.1. Hospitals
16.4.1.2. Diagnostics Centers
16.4.1.3. Academic & Research Institutes
16.4.1.4. Others (Ambulatory Surgical Centers (ASCs) etc.)
16.5. Global Smart Pills Market by Region
16.5.1. North America
16.5.2. Latin America
16.5.3. Western Europe
16.5.4. Eastern Europe
16.5.5. Asia Pacific
16.5.6. Middle East & Africa
17. Regional Analysis
17.1. North America Smart Pills Market Analysis and Forecast 2019-2028
17.1.1. Regional Market Overview and Key Takeaways
17.1.2. North America Smart Pills Market by Application
17.1.3. North America Smart Pills Market by Disease Indication
17.1.4. North America Smart Pills Market by Target Area
17.1.5. North America Smart Pills Market by End User
17.1.6. North America Smart Pills Market by Country
17.1.6.1. US
17.1.6.2. Canada
17.2. Latin America Smart Pills Market Analysis and Forecast 2019-2028
17.2.1. Regional Market Overview and Key Takeaways
17.2.2. Latin America Smart Pills Market by Application
17.2.3. Latin America Smart Pills Market by Disease Indication
17.2.4. Latin America Smart Pills Market by Target Area
17.2.5. Latin America Smart Pills Market by End User
17.2.6. Latin America Smart Pills Market by Country
17.2.6.1. Brazil
17.2.6.2. Mexico
17.2.6.3. Rest of Latin America
17.3. Western Europe Smart Pills Market Analysis and Forecast 2019-2028
17.3.1. Regional Market Overview and Key Takeaways
17.3.2. Western Europe Smart Pills Market by Application
17.3.3. Western Europe Smart Pills Market by Disease Indication
17.3.4. Western Europe Smart Pills Market by Target Area
17.3.5. Western Europe Smart Pills Market by End User
17.3.6. Western Europe Smart Pills Market by Country
17.3.6.1. Germany
17.3.6.2. UK
17.3.6.3. France
17.3.6.4. Spain
17.3.6.5. Italy
17.3.6.6. Benelux
17.3.6.7. Nordic
17.3.6.8. Rest of Western Europe
17.4. Eastern Europe Smart Pills Market Analysis and Forecast 2019-2028
17.4.1. Regional Market Overview and Key Takeaways
17.4.2. Eastern Europe Smart Pills Market by Application
17.4.3. Eastern Europe Smart Pills Market by Disease Indication
17.4.4. Eastern Europe Smart Pills Market by Target Area
17.4.5. Eastern Europe Smart Pills Market by End User
17.4.6. Eastern Europe Smart Pills Market by Country
17.4.6.1. Russia
17.4.6.2. Poland
17.4.6.3. Rest of Eastern Europe
17.5. Asia Pacific Smart Pills Market Analysis and Forecast 2019-2028
17.5.1. Regional Market Overview and Key Takeaways
17.5.2. Asia Pacific Smart Pills Market by Application
17.5.3. Asia Pacific Smart Pills Market by Disease Indication
17.5.4. Asia Pacific Smart Pills Market by Target Area
17.5.5. Asia Pacific Smart Pills Market by End User
17.5.6. Asia Pacific Smart Pills Market by Country
17.5.6.1. China
17.5.6.2. Japan
17.5.6.3. India
17.5.6.4. South Korea
17.5.6.5. Australia
17.5.6.6. ASEAN
17.5.6.7. Rest of Asia-Pacific
17.6. Middle East & Africa Smart Pills Market Analysis and Forecast 2019-2028
17.6.1. Regional Market Overview and Key Takeaways
17.6.2. Middle East & Africa Smart Pills Market by Application
17.6.3. Middle East & Africa Smart Pills Market by Disease Indication
17.6.4. Middle East & Africa Smart Pills Market by Target Area
17.6.5. Middle East & Africa Smart Pills Market by End User
17.6.6. Middle East & Africa Smart Pills Market by Country
17.6.6.1. GCC
17.6.6.2. South Africa
17.6.6.3. Turkey
17.6.6.4. Rest of the Middle East & Africa
18. Competitive Landscape
18.1. Competition Dashboard
18.1.1. Global and Regional Market Share Analysis
18.1.2. Market Structure by Geography
18.2. Competitive Benchmarking
18.3. Key Strategy Analysis
18.4. Company Profiles
18.4.1. Otsuka Holding Co., Ltd.
18.4.1.1. Company Overview
18.4.1.2. Product/Service Offerings
18.4.1.3. Financials
18.4.1.4. Recent Developments
18.4.2. CapsoVision, Inc.
18.4.2.1. Company Overview
18.4.2.2. Product/Service Offerings
18.4.2.3. Key Financials
18.4.2.4. Recent Developments
18.4.3. GE Healthcare (General Electric Company)
18.4.3.1. Company Overview
18.4.3.2. Product/Service Offerings
18.4.3.3. Financials
18.4.3.4. Recent Developments
18.4.4. Boston Scientific Corp.
18.4.4.1. Company Overview
18.4.4.2. Product/Service Offerings
18.4.4.3. Financials
18.4.4.4. Recent Developments
18.4.5. Medtronic PLC
18.4.5.1. Company Overview
18.4.5.2. Product/Service Offerings
18.4.5.3. Financials
18.4.5.4. Recent Developments
18.4.6. Olympus Corp.
18.4.6.1. Company Overview
18.4.6.2. Product/Service Offerings
18.4.6.3. Financials
18.4.6.4. Recent Developments
18.4.7. Intromedic Co. Ltd.
18.4.7.1. Company Overview
18.4.7.2. Product/Service Offerings
18.4.7.3. Financials
18.4.7.4. Recent Developments
18.4.8. RF Co. Ltd.
18.4.8.1. Company Overview
18.4.8.2. Product/Service Offerings
18.4.8.3. Financials
18.4.8.4. Recent Developments
18.4.9. Jinshan Science & Technology (Group) Co., Ltd.
18.4.9.1. Company Overview
18.4.9.2. Product/Service Offerings
18.4.9.3. Financials
18.4.9.4. Recent Developments
18.4.10. Check-Cap Ltd.
18.4.10.1. Company Overview
18.4.10.2. Product/Service Offerings
18.4.10.3. Financials
18.4.10.4. Recent Developments
18.4.11. Veloce Corporation
18.4.11.1. Company Overview
18.4.11.2. Product/Service Offerings
18.4.11.3. Financials
18.4.11.4. Recent Developments
A comprehensive list of smart pills brands/manufacturers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
19. Disclaimer
Request Sample 
Request Discount 
Inquire Before Buy
